Search Results - "Eggemann, H."

Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period by Schreiber, J., Ignatov, A., Burger, E., Meinecke, A.-M., Eggemann, H.

“…Purpose In recent years, therapeutic strategies based on tumour biology have increased significantly. We aimed to provide an overview of the recent changes in…”
Get full text

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44) by GERBER, B, LOIBL, S, KREIENBERG, R, SOLBACH, C, JACKISCH, C, KUNZ, G, BLOHMER, J. U, HUOBER, J, HAUSCHILD, M, NEKLJUDOVA, V, UNTCH, M, VON MINCKWITZ, G, EIDTMANN, H, REZAI, M, FASCHING, P. A, TESCH, H, EGGEMANN, H, SCHRADER, I, KITTEL, K, HANUSCH, C

“…We evaluated the pathological complete response (pCR) rate after neoadjuvant epirubicin, (E) cyclophosphamide (C) and docetaxel containing chemotherapy with…”
Get full text

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use by Eiermann, W., Rezai, M., Kümmel, S., Kühn, T., Warm, M., Friedrichs, K., Schneeweiss, A., Markmann, S., Eggemann, H., Hilfrich, J., Jackisch, C., Witzel, I., Eidtmann, H., Bachinger, A., Hell, S., Blohmer, J.

“…We carried out a prospective clinical study to evaluate the impact of the Recurrence Score (RS) on treatment decisions in early breast cancer (EBC). A total of…”
Get full text

Puerperal mastitis in the past decade: results of a single institution analysis by Lukassek, J., Ignatov, A., Faerber, J., Costa, S. D., Eggemann, H.

“…Purpose Although puerperal mastitis is a common disease, published data are poor. Increasing rates of community-acquired MRSA (CA-MRSA) cases are reported in…”
Get full text

BRCA1 promoter methylation is a marker of better response to platinum–taxane-based therapy in sporadic epithelial ovarian cancer by Ignatov, T., Eggemann, H., Costa, S. D., Roessner, A., Kalinski, T., Ignatov, A.

“…Background The aim of the current study was to investigate the role of BRCA1 promoter methylation as predictive factor of response to platinum–taxane-based…”
Get full text

Laparoscopic-assisted vaginal hysterectomy versus vaginal hysterectomy for benign uterine diseases: a prospective, randomized, multicenter, double-blind trial (LAVA) by Eggemann, H., Ignatov, A., Frauchiger-Heuer, H., Amse, T., Costa, S. D.

“…Objective To compare the impact of peritoneal closure on postoperative pain after vaginal (VH) and laparoscopic-assisted vaginal hysterectomy (LAVH). Study…”
Get full text

Tumor characteristics and therapy of elderly patients with breast cancer by Grumpelt, A.-M., Ignatov, A., Tchaikovski, S. N., Burger, E., Costa, S.-D., Eggemann, H.

“…Introduction Elderly breast cancer patients aged ≥75 years are underrepresented in most studies. Therefore, data on cancer characteristics, adjuvant treatment…”
Get full text

Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients by Eggemann, H., Ehricke, J., Ignatov, T., Fettke, F., Semczuk, A., Costa, S. D., Ignatov, A.

“…Elevated platelet count occasionally is associated with gynecologic malignancies. We investigated the level of platelet count in 450 patients with gynecologic…”
Get full text

1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44) by Untch, M, Von Minckwitz, G, Gerber, B, Eidtmann, H, Rezai, M, Fasching, P.A, Tesch, H, Eggemann, H, Schrader, I, Kittel, K, Hanusch, C, Huober, J, Solbach, C, Jackisch, C, Kunz, G, Blohmer, J, Hauschild, M, Fehm, T, Nekljudova, V, Loibl, S

Get full text

Intraoperative Ultrasound in the Treatment of Breast Cancer by Eggemann, H, Ignatov, T, Beni, A, Costa, S D, Ortmann, O, Ignatov, A

“…The aim of this study was to investigate the value of intraoperative ultrasound in breast-conserving operations and to compare it with standard procedures. For…”
Get full text

P206 German multicentre decision impact study of Oncotype DX recurrence score (RS) on adjuvant treatment in estrogen receptor positive (ER+) node negative (N0) and node positive (N+) early breast cancer by Blohmer, J.-U, Kühn, T, Rezai, M, Kümmel, S, Warm, M, Eggemann, H, Friedrichs, K, Eiermann, W

Get full text

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial by Schmid, P., Krocker, J., Jehn, C., Michniewicz, K., Lehenbauer-Dehm, S., Eggemann, H., Heilmann, V., Kümmel, S., Schulz, C. O., Dieing, A., Wischnewsky, M. B., Hauptmann, S., Elling, D., Possinger, K., Flath, B.

“…Background: Combinations of anthracyclines, taxanes and gemcitabine have shown high activity in breast cancer. This trial was designed to evaluate a modified…”
Get full text

Comparative study of surgical margins and cosmetic outcome in lumpectomy versus segmental resection in breast cancer by Eggemann, H, Ignatov, A, Krocker, J, Neuss, K, Elling, D, John, J, Costa, S-D

“…The aim of the present retrospective study was to compare two breast-conserving techniques, segmental resection and standard lumpectomy, for the treatment of…”
Get more information

Management der Axilla beim primär operablen Mammakarzinom by Eggemann, H., Ignatov, A., Tchaikovski, S.N., Kümmel, S., Costa, S.-D.

“…Zusammenfassung Hintergrund Die Operation der Axilla ist ein wesentlicher Bestandteil in der Behandlung des Mammakarzinoms. Im Laufe des vergangenen…”
Get full text

Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes by Kümmel, S, Eggemann, H, Lüftner, D, Gebauer, N, Bühler, H, Schaller, G, Schmid, P, Kreienberg, R, Emons, G, Kriner, M, Elling, D, Blohmer, J-U, Thomas, A

“…The insulin-like growth factor 1 (IGF1) and its binding protein IGFBP3 (insulin-like growth factor binding protein 3) play a pivotal role during the growth and…”
Get full text

Adjuvant treatment of breast cancer patients with 1–3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study by Elling, D., Eggemann, H., Kümmel, S., Breitbach, P., Kohls, A., Morack, G., Schlosser, H., Krocker, J.

“…Purpose. The efficacy of anthracyclin-containing adjuvant chemotherapy of node-positive breast cancer can be further improved by adding sequential paclitaxel…”
Get full text

Abstract P1-13-01: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel by Fasching, PA, Eggemann, H, Krocker, J, Häberle, L, Volz, B, Kleine-Tebbe, A, Blohmer, J-U, Kittel, K, Hufnagel, M, Janni, W, Emons, G, Simon, E, Köhler, U, Thomssen, C, Kohls, A, Beckmann, MW, Hielscher, C, Krabisch, P, Zeiser, T, Brodkorb, T, Baier, F, Nabieva, N, Kellner, S, Untch, M, Stadie, S, Budner, M, Breitbach, G-P, Keller, M, Stickeler, E, Kühn, T, Tolkmitt, M, Belau, AK, Schmidt, M, Ulm, K, Kümmel, S

“…Abstract Background Dose dense chemotherapy (DDT) has shown improvements of disease-free survival (DFS) and overall survival for primary breast cancer patients…”
Get full text

Abstract OT2-2-05: A prospective, randomised multi-centre phase II study evaluating the adjuvant, neoadjuvant or palliative treatment with tamoxifen +/− GnRH analogue versus aromatase inhibitor + GnRH analogue in male breast cancer patients (GBG-54 MALE) by Linder, M, von Minckwitz, G, Kamischke, A, Rudlowski, C, Eggemann, H, Nekljudova, V, Loibl, S

“…Abstract Background: Breast cancer (BC) in men is a rare disease accounting for 0.5–1% of all BC. The only available information on endocrine therapies derives…”
Get full text

Accuracy of ultrasound-guided breast-conserving surgery in the determination of adequate surgical margins by Ignatov, A, Ignatov, T, Costa, SD, Eggemann, H

“…Abstract only…”
Get full text

Ultrasound-guided breast-conserving surgery is superior to the palpation-guided surgery for palpable breast cancer by Ignatov, A, Ignatov, T, Costa, SD, Eggemann, H

“…Abstract only…”
Get full text